JERUSALEM, Israel, February 28 /PRNewswire-FirstCall/ -- IDenta Corp. announced today that it has signed a lobbying agreement with an unnamed Washington D.C. law firm. The announcement comes after several months of interviews and negotiations with a number of top lobbyists for the intended purpose of expanding the awareness and credibility of IDenta’s product line at the U.S. Department of Homeland Security and numerous other government agencies. “This agreement is a major step toward IDenta’s efforts to penetrate the most significant marketplace for our product, the U.S. Federal government,” declared IDTA CEO Yaacov Shoham. “We’ve had great success around the globe with large government agencies that by their very nature must carefully evaluate all drug detection products and use age procedures before recommending them to their of affiliates. We feel certain that this firm and the key members leading this effort will be very successful.”
IDenta recently announced that the Police Force of France has selected IDenta’s product line to recommend to the country’s police and drug enforcement agencies. IDenta’s products have received numerous major endorsements including the Romanian Police Force, the Chinese Police Force and the Commonwealth of Virginia.
The name of the lobbying firm will be announced during Shoham’s next U.S. visit which is tentatively scheduled for late March. At that time numerous meetings are expected to be scheduled with a number of high level contacts and law enforcement agencies in the U.S. government. During the trip Shoham and the new firm will begin to establish an Advisory Board, including well-know persons from the homeland security industry.
About Identa
Identa Corporation is a leading developer of proprietary on-site drug detection kits used by governments and security forces around the world. Information concerning Identa’s business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at www.identa.biz and www.drugsdetector.com.
Identa proudly supports “D.A.M.M.A.D.D.,” Dads and Mad Moms Against Drug Dealers, (www.dammadd.org)
For Investor Relations, lobbying interests or information concerning IDenta’s products internationally contact:
Yaacov Shoham, Identa Corp., CEO Tel: +972-52-6554487, +972-8-9716874 Fax: +972-8-9716875 fpi@drugsdetector.com For Investor Relations in the United States contact: Randy Jacobs, SITCOM LLC +1-800-316-9437 rjacobs@nvest.us
Certain of the statements contained herein may be, within the meaning of the federal securities laws, “forward-looking statements” that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management’s expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
IDenta Corp.
CONTACT: Yaacov Shoham, Identa Corp., CEO, Tel: +972-52-6554487,+972-8-9716874, Fax: +972-8-9716875, fpi@drugsdetector.com, Randy Jacobs,SITCOM LLC, +1-800-316-9437, rjacobs@nvest.us
